TAM
SKYE icon

Tucker Asset Management’s Skye Bioscience SKYE Stock Holding History

Tucker Asset Management’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1 Buy
+1
New +$1 ﹤0.01% 1080
2025
Q1 		– Sell
-1
Closed -$3 – 967
2024
Q4 		$3 Hold
1
– – ﹤0.01% 1536
2024
Q3 		$4 Hold
1
– – ﹤0.01% 1450
2024
Q2 		$8 Buy
+1
New +$12 ﹤0.01% 1652

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Tucker Asset Management's SKYE Position: Q4 2025 in Review

Tucker Asset Management opened a new position in Skye Bioscience (SKYE) in Q4 2025: 1 share worth $1. The stake represents ﹤0.01% of the portfolio and ranks #1080 among its holdings. This is a return to the name: Tucker Asset Management previously reported a position in SKYE as recently as Q4 2024.

Tucker Asset Management first reported a position in SKYE in Q2 2024 and has held it in 4 quarters since. The position peaked at $8 in Q2 2024. 50 funds tracked by Wall St. Rank hold SKYE as of Q4 2025.

  • Tucker Asset Management held 1 share of Skye Bioscience worth $1 as of Q4 2025.
  • Skye Bioscience was a new Tucker Asset Management position in Q4 2025.
  • Skye Bioscience made up ﹤0.01% of Tucker Asset Management's portfolio in Q4 2025, its #1080 holding.
  • Tucker Asset Management first reported a position in Skye Bioscience in Q2 2024 and has held it in 4 quarters since.
  • Tucker Asset Management's Skye Bioscience position peaked at $8 in Q2 2024.
  • 50 funds tracked by Wall St. Rank held Skye Bioscience as of Q4 2025.

Based on Tucker Asset Management's 13F filing for Q4 2025, filed 5 Feb 2026.